Please join us in the Boston office of Foley & Lardner LLP, together with the Hellenic Innovation Network, on Wednesday, May 4 @ 5:30 p.m. ET for an exciting in-person event, “Frontiers in Life Sciences, the Greek Connection.” The program will include a Fireside Chat with Michel Vounatsos, CEO of Biogen and Nicholas Galakatos, Global Head of Life Sciences at Blackstone, and will be moderated by Anna Protopapas, CEO of Mersana Therapeutics.
Following the discussion, Greek entrepreneurs will pitch their startups, which are fundraising for US expansion.
A cocktail networking reception will follow.
Event Agenda:
- 5:30-6:00 – Networking Reception
- 6:00-7:15 – Fireside Chat, Pitches, Achievement Awards
- 7:15 – 8:30 – Cocktail Networking Reception
To view the invitation and RSVP, please click here.
People
Related Insights
March 27, 2026
Tariff & International Trade Resource
What Every Multinational Should Know About … How to Cope with New Court Decisions Expanding Supply Chain Integrity Risks: Six Steps for Enhancing Supply Chain Compliance
Supply chain integrity and economic sanctions compliance failures may now carry risks that extend far beyond traditional regulatory enforcement. In certain circumstances, they may serve as the evidentiary foundation for large-scale civil litigation tied to supply-chain integrity, terrorism financing, or human rights abuses.
March 26, 2026
The Path & The Practice
Episode 133: Joe Dowdy, Partner
Joe is a litigator and the managing partner of Foley’s Raleigh office. He reflects on growing up on farm in Powells Point, NC, attending the University of North Carolina at Chapel Hill for undergrad and the University of North Carolina School of Law.
April 30, 2026
Events
April 2026 Midwest Cyber Security Alliance Meeting | CMMC: Navigating the Road from Scope to Assessment
The panel will navigate the full CMMC life cycle, starting with applicability and organizational fit. They will then dive into technical strategy and governance, the nuances of outsourcing to MSPs, what C3PAO auditors specifically look for, and the legal risks for your organization to consider throughout the process.